Abstract:Abstract Background/Objective: Tanshinone IIA, which is mainly used for the treatment of cardiovascular diseases, has been shown to inhibit the progression of a variety of cancers in recent years. In this study, we showed that tanshinone IIA could inhibit the proliferation of triple-negative breast cancer cells and promote their apoptosis. However, the specific mechanisms were not clear. Our research aims to clarify its mechanism. Method: At the first, the effects of tanshinone IIA on cell viability of triple-negative breast cancer cell lines were analyzed. Then a mouse transplanted tumor model was used to study the anti-cancer effect in vivo. The related targets and mechanisms of tanshinone IIA were predicted through network-based systems biology and molecular docking analysis. At last, molecular docking and the molecular biological techniques were used to evaluate the predicted target. Results: Tanshinone IIA could inhibit the cell proliferation after incubation for 24 h. At a concentration of 50 µM, Tanshinone IIA could half-inhibit the proliferation of 4T1 cells. Consistent with the results of the cell viability assays, Tan IIA induced the cancer cell apoptosis and resulted in a significant reduction in tumor volume. Then we analyzed the possible mechanisms with network-based systems biology, and predicted TP53, NF-κB, AKT, MYC and BCL-2 were the hub targets of Tan IIA for triple-negative breast cancer. P53 signaling pathway, PI3K/Akt pathway, the MAPK signaling pathway and the mTOR signaling pathways were the possible involved mechanisms. Using molecular docking analysis, we found Tan IIA has a high affinity for p53, Bcl-2 and NF-κB1, the binding energy were − 6.92, -6.07 and − 6.28 kcal/mol, respectively. Through western blotting assays, we further found the p53 protein expression was increased while Bcl-2 protein was decreased after Tan IIA treatment. These results verified that Tan IIA promotes apoptosis by down-regulating BCL2 and up-regulating TP53 in triple-negative breast cancer.Conclusion: Our findings revealed the mechanism of Tan IIA in promoting apoptosis and inhibiting proliferation in triple-negative breast cancer cells, which provides a theoretical and experimental basis for further research into the anticancer effects of Tan IIA.

Tanshinone IIA Inhibits Growth of Keratinocytes Through Cell Cycle Arrest and Apoptosis: Underlying Treatment Mechanism of Psoriasis.

Tanshinone II A Attenuates TNF-α-Induced Expression of VCAM-1 and ICAM-1 in Endothelial Progenitor Cells by Blocking Activation of NF-κB.

Tanshinone IIA, a component of the self‐made Xiao‐Yin decoction, ameliorates psoriasis by inhibiting IL‐17/IL‐23 and PTGS2/NF‐κB/AP‐1 pathways

Tanshinone IIA activates calcium-dependent apoptosis signaling pathway in human hepatoma cells

Tanshinone IIA Promotes Apoptosis by Down-Regulating BCL2 and Up-Regulating TP53 in Triple-Negative Breast Cancer

Inactivation of PI3k/Akt Signaling Pathway and Activation of Caspase-3 Are Involved in Tanshinone I-induced Apoptosis in Myeloid Leukemia Cells in Vitro

Tanshinone Iia Inhibits Proliferation And Induces Apoptosis Through The Downregulation Of Survivin In Keloid Fibroblasts

Tanshinone IIA Arrests Cell Cycle and Induces Apoptosis in 786-O Human Renal Cell Carcinoma Cells

Tanshinone IIA inhibits leukemia THP-1 cell growth by induction of apoptosis

Mechanism of Danshensu-Induced Inhibition of Abnormal Epidermal Proliferation in Psoriasis.

Tanshinone IIA: New Perspective on the Anti-Tumor Mechanism of A Traditional Natural Medicine.

Tanshinol ameliorates imiquimod-induced psoriasis by inhibiting M1 macrophage polarization through suppression of the notch signaling pathway

Tanshinone IIA Suppresses Proliferation and Inflammatory Cytokine Production of Synovial Fibroblasts from Rheumatoid Arthritis Patients Induced by TNF-α and Attenuates the Inflammatory Response in AIA Mice

Tanshinone IIA promotes apoptosis by downregulating BCL2 and upregulating TP53 in triple-negative breast cancer

Tanshinone IIA suppresses ovarian cancer growth through inhibiting malignant properties and angiogenesis

Tanshinone IIA Triggers P53 Responses and Apoptosis by RNA Polymerase II Upon DNA Minor Groove Binding.

Tanshinone IIA induces apoptosis and inhibits the proliferation, migration, and invasion of the osteosarcoma MG-63 cell line in vitro.

Tanshinone IIA induces cell death via Beclin-1-dependent autophagy in oral squamous cell carcinoma SCC-9 cell line

Tanshinone IIA ameliorates the development of dermal fibrosis in systemic sclerosis

Shikonin Induces Apoptosis and Suppresses Growth in Keratinocytes Via CEBP-δ Upregulation.

Pulsatilla saponin inhibits the proliferation of keratinocytes and ameliorates imiquimod-induced psoriasis through the NF-κB and STAT3 signaling pathways